Open Access

Reactogenicity and safety of AS03B-adjuvanted H5N1 influenza vaccine in children: an open-label, one-way, crossover trial

Patricia Izurieta

Patricia Izurieta

GSKWavre, Belgium
Search for this author on
Sciendo|Google Scholar
Izurieta, Patricia
, 
Pope Kosalaraksa

Pope Kosalaraksa

Department of Pediatrics, Khon Kaen UniversityKhon Kaen, Thailand
Search for this author on
Sciendo|Google Scholar
Kosalaraksa, Pope
, 
Louise Frenette

Louise Frenette

Q&T ResearchSherbrooke, Canada
Search for this author on
Sciendo|Google Scholar
Frenette, Louise
, 
Mamadou Dramé

Mamadou Dramé

GSKKing of Prussia, USA
Search for this author on
Sciendo|Google Scholar
Dramé, Mamadou
, 
Bruce L. Innis

Bruce L. Innis

Vaccines Discovery and Development, GSKKing of Prussia, USA
Search for this author on
Sciendo|Google Scholar
Innis, Bruce L.
, 
David W Vaughn

David W Vaughn

Vaccines Discovery and Development, GSKKing of Prussia, USA
Search for this author on
Sciendo|Google Scholar
Vaughn, David W
 and 
Anne Schuind

Anne Schuind

Vaccines Discovery and Development, GSKKing of Prussia, USA
Search for this author on
Sciendo|Google Scholar
Schuind, Anne
  
Mar 21, 2018
Reactogenicity and safety of AS03B-adjuvanted H5N1 influenza vaccine in children: an open-label, one-way, crossover trial's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Brief communication
Published Online: Mar 21, 2018
Page range: 359 - 364
DOI: https://doi.org/10.1515/abm-2018-0008
Keywords
© 2017 Patricia Izurieta, Pope Kosalaraksa, Louise Frenette, Mamadou Dramé, Bruce L. Innis, David W Vaughn, Anne Schuind
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, Basic Medical Science, other, Clinical Medicine, Clinical Medicine, other
Journal RSS Feed